10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001558370-21-010617`
Period End Date	20210630
Filing Date	20210805
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	iova-20210630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 36 Cash Flow Statement 55 Stockholders Equity 36 Comprehensive Income 12

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$160.61M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$82.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$67.33M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$562.11M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$573.61M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.27M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.66M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$636.10M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$666.64M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$80.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$59.16M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$52.51M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$54.76M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	154.80M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$46.29M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	146.87M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	146.87M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	154.80M	shares	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$1.15M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$12.92M	USD	Point-in-time
Total Assets	`Assets`	$852.79M	USD	Point-in-time
Total Assets	`Assets`	$768.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$13.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.91M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$34.19M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$35.07M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$6.28M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$4.43M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$60.53M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$54.87M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$46.84M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$45.38M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.71M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$57.09M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$47.84M	USD	Point-in-time
Total Liabilities	`Liabilities`	$108.38M	USD	Point-in-time
Total Liabilities	`Liabilities`	$111.96M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 154,799,721 and 146,874,917 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 154,799,721 and 146,874,917 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$33.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$19.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.49B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.73B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-830.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-986.99M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$744.41M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$647.43M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$758.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$243.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$656.50M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$768.46M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$852.79M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$62.12M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$118.07M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$106.23M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$49.27M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$19.31M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$14.35M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$28.21M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$38.93M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$134.44M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$63.63M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$157.00M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$81.43M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-134.44M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-63.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-81.43M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-157.00M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$196.00K	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$609.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$1.82M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$75.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.04	USD	2 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.47	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.02	USD	2 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.53	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.53	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.02	USD	2 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.47	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.04	USD	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	133,162.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	129,848.00	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	150,571.00	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153,751.00	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$19.95M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.36M	USD	2 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$2.41M	USD	2 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$3.33M	USD	2 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$3.86M	USD	2 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$-17.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$512.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$738.00K	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-8.16M	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.06M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$159.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-3.74M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-388.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.95M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-7.10M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$18.81M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-10.52M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-116.40M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-101.93M	USD	2 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$320.15M	USD	2 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$216.68M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$381.78M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$534.72M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.32M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.61M	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-323.65M	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-81.95M	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$283.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$5.19M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$10.19M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.39M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$203.16M	USD	2 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$214.35M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$572.30M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$15.99M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$146.72M	USD	2 Qtrs
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.14M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.14M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Net unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$14.00K	USD	2 Qtrs
Net unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$97.00K	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$5.21M	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$1.38M	USD	2 Qtrs
Accrued offering costs in accrued expenses	`AccruedOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction`	$393.00K	USD	2 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$647.43M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.41M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.95M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.36M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.54M	USD	1 Quarter
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$970.00K	USD	1 Quarter
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$970.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-165.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-283.00K	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.74M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.22M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.19M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.24M	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$160.27M	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.00M	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.00M	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$203.16M	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$97.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-63.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-595.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$647.43M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-63.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-132.61M	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$97.00K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-63.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-595.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-81.41M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-132.52M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-156.79M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-63.61M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.